Venothrombotic Events: Evidence-Based Risk Assessment, Prophylaxis, Diagnosis, and Treatment

Blum, Cindy

doi:10.1016/j.nurpra.2008.07.009

Cited by 5 publications

(6 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recognizing the mortality and morbidity associated with VTE, multiple national groups have identified regulations for assessing, preventing, and reporting these events. [2][3][4] The National Quality Forum endorsed the use of a multidisciplinary approach for risk assessment and prophylaxis guidelines during hospitalizations and for establishing evidence-based guidelines for inpatient and postdischarge prophylaxis. 5 As of July 31, 2008, the Centers for Medicaid and Medicare Services implemented requirements in the adult population stating that hospital reimbursement will be for services not related to complications when a DVT or pulmonary embolism develops after hip or total knee replacement.…”

mentioning

confidence: 99%

“…Those hospitals not meeting this requirement could lose 2% of Medicare reimbursement for the year. 2 Venous thromboembolism is an extremely serious and potentially fatal condition and is considered very preventable. The literature concerning assessment, complications, and prevention in adults is abundant, but little is known about pediatric and neonatal patients.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Early Recognition of Pediatric Venous Thromboembolism: A Risk-Assessment Tool

Prentiss

2012

American Journal of Critical Care

View full text Add to dashboard Cite

BackgroundThe incidence of venous thromboembolism in children has increased dramatically, with most cases occurring in children with cancer, surgery, trauma, congenital heart disease, and systemic lupus erythematosus. Early assessment of risk factors present in children would minimize morbidity and mortality from these events. Objectives To evaluate the reliability and validity of a tool for assessing risk for venous thromboembolism in children. Methods The tool was developed after a review of the literature with assessment of content validity by a multidisciplinary team of experts. Patients' charts were reviewed retrospectively to establish reliability and validity of the tool. A P value less than .05 was considered statistically significant. Results Thirty-five charts were assessed for tool validity and were found to be statistically significant for all 3 risk score assessment categories. Logistic regression was used to assess 1001 patients' charts for internal consistency, which was found to be high (χ 2 5 [n = 1001] = 100.6, P < .001). Results indicated that most patients at risk for venous thromboembolism were between the ages of 13 and 17 years, with females having more than 7 times greater risk than males. Conclusions Descriptive statistics show that the assessment tool displays strong reliability and validity. Results validated a significant relationship between the risk score and the incidence of venous thromboembolism. Findings suggest that use of the assessment tool could significantly reduce adverse outcomes associated with venous thromboembolism in children. Notice to CE enrollees:A closed-book, multiple-choice examination following this article tests your under standing of the following objectives:1. Identify factors associated with increased risk for development of venous thromboembolism (VTE) in pediatric patients. 2. Describe study findings regarding the relationship between the total score on the risk assessment tool and the incidence of VTE in pediatric patients. 3. Discuss opportunities for future research related to VTE in pediatric patients.

show abstract

mentioning

confidence: 99%

mentioning

confidence: 99%

Early Recognition of Pediatric Venous Thromboembolism: A Risk-Assessment Tool

Prentiss

2012

American Journal of Critical Care

View full text Add to dashboard Cite

show abstract

“…Nurses are in constant contact with patients during the postoperative period and can actively promote noninvasive VTE prophylactic practices such as leg elevation, early/consistent mobility, foot exercises, prevention of dehydration and performing ongoing assessments of patients with risk or signs and symptoms of VTE. These simple nursing measures can actively involve the patient with proactive management of VTE prophylactic practices (Autar, ; McCaffrey & Blum, ).…”

Section: Discussionmentioning

confidence: 99%

Evaluation of a nurse‐led intervention to improve adherence to recommended guidelines for prevention of venous thromboembolism for hip and knee arthroplasty patients: A quasi‐experimental study

Lockwood

Kable

Hunter

2018

Journal of Clinical Nursing

View full text Add to dashboard Cite

show abstract

“…Venous thromboembolism (VTE) comprises of a group of conditions including deep vein thrombosis (DVT) and pulmonary embolism (PE). VTE is associated with bad mortality, morbidity rates and additional economic burden to healthcare systems [1,2]. DVT was described through Virchow's triad due to vessels wall injury, venous stasis or hypercoagulability.…”

Section: Introductionmentioning

confidence: 99%

Assessment of Deep Vein Thrombosis (DVT) incidence among ambulatory cancer patients in Qatar: A retrospective cohort study

Abdelwahab¹,

Hamad²,

Negm³

et al. 2021

GSC Biol. and Pharm. Sci.

View full text Add to dashboard Cite

Background: Thromboprophylaxis of ambulatory cancer patients is considered controversial. However, some guidelines suggest conducting VTE risk assessment using the Khorana risk assessment scoring model. This study aims to assess the incidence of Deep Vein Thrombosis (DVT) and related cancer types, focusing on the incidence of DVT in ambulatory patients actively on chemotherapy, with Khorana risk score (KRS). Methods: The Doppler ultrasound reports over 12-month period were reviewed. A total of 205 patients were included in the study. Patients with DVT were screened for the relevant biomarkers in KRS model and any other additional risk factors. Furthermore, a comparison between ambulatory patients who developed DVT and those who did not, was carried on determining the KRS association with incidence. Results: The incidence of DVT in ambulatory cancer patients was higher than the inpatient setting (23% vs. 8%). Breast cancer was the most common malignancy associated with DVT (30%) followed by colon cancer (17%). Chemotherapy increased the incidence of DVT in ambulatory patients (29% vs. 13%). Patients with KRS of ≥2 were more likely to develop DVT (37.5%). Conclusion: This study highlights the importance of conducting a thorough DVT risk assessment for ambulatory cancer patients on chemotherapy and the need to look for KRS to reconsider additional risk factors.

show abstract

Venothrombotic Events: Evidence-Based Risk Assessment, Prophylaxis, Diagnosis, and Treatment

Cited by 5 publications

References 19 publications

Early Recognition of Pediatric Venous Thromboembolism: A Risk-Assessment Tool

Early Recognition of Pediatric Venous Thromboembolism: A Risk-Assessment Tool

Evaluation of a nurse‐led intervention to improve adherence to recommended guidelines for prevention of venous thromboembolism for hip and knee arthroplasty patients: A quasi‐experimental study

Assessment of Deep Vein Thrombosis (DVT) incidence among ambulatory cancer patients in Qatar: A retrospective cohort study

Contact Info

Product

Resources

About